Home
Ingredients
Analysis
Manufacturing
Finance
Events
Directory
Regulatory
Drug Delivery
Research & Development
Sustainability
Breaking News
Molecule discovery holds promise for gene therapies for psoriasis
Scientists at the University of Birmingham have discovered a protein that could hold the key to novel gene therapies for skin problems including ps...
Global dermatology market set to reach US$33.7bn by 2022, despite patent expiries
Growth will be driven by a strong late-stage pipeline, which includes several highly valuable targeted therapies
Allergan acquires Topokine Therapeutics to focus on non-invasive fat reduction programme
Acquisition adds to Allergan's robust mid-to-late stage pipeline and reinforces its leadership in aesthetics innovation
Animal-free approach to metabolism studies
For assessing the effect of candidate drugs and consumer use chemicals in human skin
Researchers invent novel microneedle patch
National University of Singapore research team develops simple technique for faster and more effective delivery of painkiller and collagen
Venn Life Sciences acquires trading assets of Evocutis
Including intellectual property rights to Labskin and anti-acne compound SYN1113
Merz Pharma acquires Swiss dermatology company Neocutis
Will strengthen its aesthetics business, and particularly its business in the US
UK-Norwegian team to develop living skin equivalent testing model
For testing inflammatory responses
Evocutis and Bradford University Collaborate on pigmented LabSkin
Aim to discover improved ways of investigating common pigment-related skin conditions
In Brief
Intertek Clinical Research Services moves to new laboratory facility
InformEx USA 2011
Most Popular in Skin Care
DKSH acquires Tiger Chemicals Company
Merz Pharma acquires Swiss dermatology company Neocutis
